20/20 Biolabs, Inc. (AIDX)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $0.25
- As of
Kresmion compiles this page from AIDX's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
20/20 Biolabs, Inc. (AIDX): 1 institutional manager tracked by Kresmion reported non-option positions in their 2026Q2 Form 13F filings, and the most recent SEC filing on record for the company is a Form 8-K filed 2026-09-18.
See the full AIDX dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for AIDX on one page. Preview it with sample data, then open it live with a free account.
Preview the AIDX dossierActive events for AIDX
- mediumEarnings below estimates
Q2-2026: Missed consensus by 104.2%, EPS $-0.25 vs $-0.1224 estimate
- medium13F: new position
CITADEL ADVISORS LLC new position in AIDX
FREE, NO ACCOUNT
Every event on AIDX, as it fires
New filings, 13F moves and cross asset events on AIDX land in the record first.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
Largest reported share positions in AIDX (2026Q2)
| Manager / security | Market value | % portfolio | QoQ |
|---|---|---|---|
| CITADEL ADVISORS LLCCUSIP 90138K101 · 2026Q2 | $13K | 0.00% | , |
Quarterly SEC Form 13F disclosures from the managers Kresmion tracks, not a complete ownership ranking. Non-option holdings only; reported put and call positions are excluded. Different securities are labeled by CUSIP. Values are reporting-period snapshots, not current position values. Filings can arrive up to 45 days after quarter-end.
Recent SEC filings, AIDX
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
AIDX against its peers
AIDX's operating margin of -162.9% ranks in the 57th percentile of 14 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-06-30.
| Metric | AIDX | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 2.0M USD | 3.3M USD | 42 | 17 |
| Gross margin | 29.6% | 59.8% | 25 | 13 |
| Operating margin | -162.9% | -311.7% | 57 | 14 |
| Net margin | -182.8% | -318.4% | 66 | 15 |
| Return on equity | n/a | -222.5% | n/a | 16 |
Peers (20): ADGM, RMSL, IVF, BJDX, ADMT, NUWE, VYCO, CODX, XAIR, VVOS, STME, ICCM, NXL, USAQ, INBS, WOK, AMIX, NVNO, VNRX, TNON. Left out: PMEDF (period gap), FZMD (period gap), CSDX (no annual filing), KLYG (no annual filing), TRIB (period gap). Fiscal periods ending between 2025-09-30 and 2026-06-30. Every figure is one full fiscal year read from one annual filing (AIDX: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Related tickers
Follow AIDX on a live board
Kresmion is a cross-asset market-intelligence terminal. Open a board scoped to AIDX for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.